December 28, 2014 3:50 AM ET

Pharmaceuticals

Company Overview of H3 Biomedicine Inc.

Executive Profile

Todd R. Golub M.D.

Founding Advisor, Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 7 different industries.

See Board Relationships
----

Background

Dr. Todd R. Golub, M.D. serves as Scientific Founder at H3 Biomedicine Inc. Dr. Golub is the Founding Director of the Cancer Program at the Broad Institute of Harvard and MIT, and also serves as the Institute’s Chief Scientific Officer. Dr. Golub is also the Charles A. Dana Investigator at the Dana-Farber Cancer Institute, Professor of Pediatrics at Harvard Medical School, and an investigator at the Howard Hughes Medical Institute. Dr. Golub is internationally known ...

Corporate Headquarters

300 Technology Square
Cambridge, Massachusetts 02139

United States

Phone: 617-252-5000
Fax: --

Board Members Memberships

Director

Education

BA 1985
Carleton College
MD 1989
University Of Chicago - Pritzker School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$400.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$649.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact H3 Biomedicine Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.